H.R. 7970: STOP Nitazenes Act
H.R. 7970 status: Introduced.
What this bill does
Overall score
Bill summary
No official summary is available for this bill yet.
Key analysis
Impact analysis
Environment
Benefits
- No direct environmental benefit identified
Risks
- No direct environmental risk identified
Economy
Benefits
- May reduce costs associated with drug treatment and law enforcement related to nitazenes.
Risks
- Potential for increased black market activity if enforcement is not effective.
Society
Benefits
- Permanently schedules dangerous nitazene opioids as Schedule I controlled substances.
- Aims to curb the proliferation and availability of highly potent and lethal synthetic opioids.
- Provides Attorney General with authority to list related substances.
Risks
- Does not address root causes of opioid addiction.
- May not prevent the development of new, unscheduled analogues.
How trustworthy & consequential it is
Confidence
highhigh
Information is complete and verified.
Analysis status
Full bill text (Congress.gov)
Source used for this bill's analysis.
The scheduling of these substances may lead to the emergence of new, unscheduled designer drugs.
The bill relies on the Attorney General to identify and list specific nitazene analogues.
Where it stands
Introduced
CurrentIntroduced
Committee
UpcomingFloor
UpcomingEnacted
UpcomingHow it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.